125 related articles for article (PubMed ID: 12737530)
1. APP processing enzymes (secretases) as therapeutic targets: insights from the use of transgenics (Tgs) and transfected cells.
Marks N; Berg MJ
Neurochem Res; 2003 Jul; 28(7):1049-62. PubMed ID: 12737530
[TBL] [Abstract][Full Text] [Related]
2. The presenilins in Alzheimer's disease--proteolysis holds the key.
Haass C; De Strooper B
Science; 1999 Oct; 286(5441):916-9. PubMed ID: 10542139
[TBL] [Abstract][Full Text] [Related]
3. Secretases as therapeutic targets for the treatment of Alzheimer's disease.
Dominguez DI; De Strooper B; Annaert W
Amyloid; 2001 Jun; 8(2):124-42. PubMed ID: 11409035
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
5. Secretases as targets for the treatment of Alzheimer's disease: the prospects.
Dewachter I; Van Leuven F
Lancet Neurol; 2002 Nov; 1(7):409-16. PubMed ID: 12849363
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein compartmentalization restricts beta-amyloid production: therapeutic targets based on BACE compartmentalization.
Gandhi S; Refolo LM; Sambamurti K
J Mol Neurosci; 2004; 24(1):137-43. PubMed ID: 15314262
[TBL] [Abstract][Full Text] [Related]
7. Regulation of APP cleavage by alpha-, beta- and gamma-secretases.
Nunan J; Small DH
FEBS Lett; 2000 Oct; 483(1):6-10. PubMed ID: 11033346
[TBL] [Abstract][Full Text] [Related]
8. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP.
Neve RL
Trends Neurosci; 2003 Sep; 26(9):461-3. PubMed ID: 12948653
[TBL] [Abstract][Full Text] [Related]
9. Toward the characterization and identification of gamma-secretases using transition-state analogue inhibitors.
Moore CL; Diehl TS; Selkoe DJ; Wolfe MS
Ann N Y Acad Sci; 2000; 920():197-205. PubMed ID: 11193150
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
11. Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases.
Zhang W; Espinoza D; Hines V; Innis M; Mehta P; Miller DL
Biochim Biophys Acta; 1997 Nov; 1359(2):110-22. PubMed ID: 9409808
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta/A4 precursor protein (APP) processing in lysosomes.
Tagawa K; Maruyama K; Ishiura S
Ann N Y Acad Sci; 1992 Dec; 674():129-37. PubMed ID: 1288358
[TBL] [Abstract][Full Text] [Related]
13. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
De Strooper B; Annaert W; Cupers P; Saftig P; Craessaerts K; Mumm JS; Schroeter EH; Schrijvers V; Wolfe MS; Ray WJ; Goate A; Kopan R
Nature; 1999 Apr; 398(6727):518-22. PubMed ID: 10206645
[TBL] [Abstract][Full Text] [Related]
14. Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells.
Pitsi D; Kienlen-Campard P; Octave JN
J Neurochem; 2002 Oct; 83(2):390-9. PubMed ID: 12423249
[TBL] [Abstract][Full Text] [Related]
15. Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.
Li YM
Mol Interv; 2001 Oct; 1(4):198-207. PubMed ID: 14993342
[TBL] [Abstract][Full Text] [Related]
16. APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations.
Bergman A; Religa D; Karlström H; Laudon H; Winblad B; Lannfelt L; Lundkvist J; Näslund J
Exp Cell Res; 2003 Jul; 287(1):1-9. PubMed ID: 12799176
[TBL] [Abstract][Full Text] [Related]
17. The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition.
Younkin SG
Tohoku J Exp Med; 1994 Nov; 174(3):217-23. PubMed ID: 7761987
[TBL] [Abstract][Full Text] [Related]
18. Nicastrin binds to membrane-tethered Notch.
Chen F; Yu G; Arawaka S; Nishimura M; Kawarai T; Yu H; Tandon A; Supala A; Song YQ; Rogaeva E; Milman P; Sato C; Yu C; Janus C; Lee J; Song L; Zhang L; Fraser PE; St George-Hyslop PH
Nat Cell Biol; 2001 Aug; 3(8):751-4. PubMed ID: 11483961
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
[TBL] [Abstract][Full Text] [Related]
20. Implication of APP secretases in notch signaling.
Hartmann D; Tournoy J; Saftig P; Annaert W; De Strooper B
J Mol Neurosci; 2001 Oct; 17(2):171-81. PubMed ID: 11816790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
